May 28, 2022 4:36 PM
BACK TO TOP
KSE100
42,861.45
319.74
(0.75%)
ALLSHR
29,257.53
230.68
(0.79%)
KSE30
16,276.12
133.09
(0.82%)
KMI30
69,055.39
597.56
(0.87%)
BKTi
11,870.79
30.79
(0.26%)
OGTi
10,735.28
97.75
(0.92%)
KMIALLSHR
21,000.61
185.67
(0.89%)
UPP9
11,123.70
81.65
(0.74%)
NITPGI
8,929.02
60.71
(0.68%)
NBPPGI
10,613.27
62.17
(0.59%)
MZNPI
8,676.95
62.21
(0.72%)
JSMFI
10,488.56
147.87
(1.43%)
ACI
8,265.60
74.83
(0.91%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.124.45
1.55
(1.26%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, May 27, 2022 5:12 PM
REG
FUT
ODL
Open
123.01
High
125.95
Low
123.01
Volume
22,900
CIRCUIT BREAKER
113.68 — 132.12
DAY RANGE
123.01 — 125.95
52-WEEK RANGE
120.00 — 173.50
Ask Price
124.45
Ask Volume
1,900
Bid Price
0.00
Bid Volume
0
LDCP
122.90
VAR
11.00
HAIRCUT
15.00
P/E Ratio (TTM) **
7.14
1-Year Change *
-16.12%
YTD Change *
-8.83%

No record found

Open
124.00
High
127.00
Low
123.00
Close
127.00
Change
3.34%
LDCP
122.90
Volume
83
Total Trades
8
CIRCUIT BREAKER
110.61 — 135.19
DAY RANGE
123.00 — 127.00
Ask Price
122.20
Ask Volume
25
Bid Price
122.11
Bid Volume
5
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).

KEY PEOPLE
Ms. Erum Shakir RahimCEO
Mr. Dmytro OliinykChairman
Ms. Mehar-e-daraksha AmeerCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.pk.gsk.com

REGISTRAR

CDC Share Registrar Services Limited CDC House, 99 - B, Block - B S.M.C.H.S., Main Shahra-e-Faisal Karachi

AUDITOR

Yousuf Adil, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
39,633,252.75
Shares
318,467,278
Free Float
52,071,067
Free Float
16.35%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
May 6, 2022Transmission of Quarterly Report for the Period Ended March 31, 2022 View   PDF
Apr 26, 2022Financial Results for the Quarter Ended March 31, 2022 View   PDF
Apr 4, 2022Transmission of Annual Report for the Year Ended 2021-12-31 View   PDF
Feb 25, 2022Financial Results for the Year Ended December 31 2021 View   PDF
Oct 29, 2021Transmission of Quarterly Report for the Period Ended September 30, 2021 View   PDF
Oct 25, 2021Financial Results for the Quarter Ended September 30, 2021 View   PDF
Aug 27, 2021Transmission of Quarterly Report for the Period Ended 2021-06-30 View   PDF
Aug 23, 2021Financial Results for the Quarter ended June 30, 2021 View   PDF
May 17, 2021CREDIT OF FINAL CASH DIVIDEND (D-98) FOR THE YEAR ENDED DECEMBER 31, 2020 View   PDF
Apr 30, 2021Transmission of Quarterly Report for the Period Ended 2021-03-31 View   PDF
Apr 28, 2021Financial Results for the Quarter ended March 31, 2021 View   PDF
Apr 6, 2021Transmission of Annual Report for the Year Ended 2020-12-31 View   PDF
DateTitleDocument
Apr 25, 2022Board Meeting In Progress View   PDF
Apr 25, 2022Certified True Copy of Resolution - Annual General Meeting View   PDF
Apr 18, 2022Board Meeting View   PDF
Apr 4, 2022Notice of Annual General Meeting View   PDF
Feb 18, 2022BOARD OF DIRECTORS MEETING View   PDF
Oct 18, 2021Board of Directors Meeting View   PDF
Aug 20, 2021Board Meeting Reschedule View   PDF
Aug 16, 2021Board of Directors Meeting View   PDF
Apr 27, 2021MEETING IN PROGRESS View   PDF
Apr 20, 2021Board of Directors Meeting View   PDF
Apr 6, 2021Notice of Annual General Meeting View   PDF
Apr 6, 2021Notice of Annual General Meeting View   PDF
DateTitleDocument
May 10, 2022Credit of Final Cash Dividend 2021 View   PDF
May 6, 2022PRIOR PUBLICAITON NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND View   PDF
Mar 30, 2022Prior Publication of AGM Notice for the year 2021 View   PDF
Dec 6, 2021Corporate Briefing Session View   PDF
Sep 17, 2021CONVERSION OF PHYSICAL SHARES INTO BOOK ENTRY FORM View   PDF
Jun 1, 2021Appointment of Chief Financial Officer and Executive Director View   PDF
May 4, 2021PRIOR PUBLICATION NOTICE OF DIRECT CREDIT OF FINAL CASH DIVIDEND View   PDF
Apr 27, 2021CERTIFIED TRUE COPY OF RESOLUTION View   PDF
Mar 31, 2021Material Information View   PDF
Mar 9, 2021GLAXO | GlaxoSmithKline Pakistan Limited PDF
Jan 1, 2021Change of the Company Secretary View   PDF
Jan 1, 2021CHANGE OF THE COMPANY SECRETARY View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2021202020192018
Sales36,660,77235,090,11236,581,74934,006,840
Profit after Taxation5,354,4093,375,2403,041,1233,257,951
EPS16.8110.609.5510.23
Q1 2022Q3 2021Q2 2021Q1 2021
Sales8,625,9649,825,2269,058,0947,693,509
Profit after Taxation925,0411,195,203977,497725,547
EPS2.903.753.072.28
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2021202020192018
Gross Profit Margin (%)26.5621.4721.0824.74
Net Profit Margin (%)14.619.628.319.58
EPS Growth (%)58.5810.99(6.65)9.29
PEG0.141.65(2.53)1.19

Payouts

DateFinancial ResultsDetailsBook Closure
February 28, 2022 11:32 AM31/12/2021(YR) 70%(F) (D) 19/04/2022 - 25/04/2022
March 10, 2021 3:45 PM31/12/2020(YR) 65%(F) (D) 21/04/2021 - 27/04/2021
March 11, 2020 5:58 PM31/12/2019(YR) 60%(F) (D) 15/05/2020 - 21/05/2020
March 4, 2019 4:53 PM31/12/2018(YR) 70%(F) (D) 18/04/2019 - 24/04/2019
February 27, 2018 3:59 PM31/12/2017(YR) 40% (D) 18/04/2018 - 24/04/2018
October 26, 2017 5:47 PM30/09/2017(IIIQ) 30% (D) 10/11/2017 - 17/11/2017
March 8, 2017 4:03 PM31/12/2016(YR) 60% (D) 18/04/2017 - 24/04/2017
March 30, 2016 3:13 PM31/12/2015(YR) 40% (D) 20/04/2016 - 27/04/2016
February 25, 2015 3:51 PM31/12/2014(YR) 50% (D) 16/04/2015 - 23/04/2015
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014

Financial Reports